APC anti-human CD366 (Tim-3) Antibody
- 产品名称：
- APC anti-human CD366 (Tim-3) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 345011
- 产品应用：
- 345011
[价格]
| 规格 |
价格 |
库存 |
| 25tests |
￥ 1932 |
1 |
- Verified Reactivity
- Human
- Antibody Type
- Monoclonal
- Host Species
- Mouse
- Immunogen
- Human Tim-3 fusion protein
- Formulation
- Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide and BSA (origin USA)
- Preparation
- The antibody was purified by affinity chromatography and conjugated with APC under optimal conditions.
- Concentration
- Lot-specific (to obtain lot-specific concentration, please enter the lot number in our Concentration and Expiration Lookup or Certificate of Analysis online tools.)
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is 5 ?l per million cells in 100 ?l staining volume or 5 ?l per 100 ?l of whole blood.
- Excitation Laser
- Red Laser (633 nm)
- Application Notes
Additional reported applications (for relevant formats of this clone) include: costimulation1 (clone 2E2 has been shown to enhance T-cell receptor mediated activation and cytokine secretion) and blocking2,3.
- Application References
(PubMed link indicates BioLegend citation) -
- Hastings WD, et al. 2009. Eur. J. Immunol. 39:2492. (Costim)
- Jones RB, et al. 2008. J. Exp. Med. 205:2763. (Block)
- Klibi J, et al 2009. Blood 113:1957. (FC, Block)
- Product Citations
-
- Iwahori K, et al. 2019. Sci Rep. 2.205555556. PubMed
- Muliaditan T, et al. 2021. Cell Rep Med. 2:100457. PubMed
- Chen M, et al. 2021. Cancers (Basel). 13:. PubMed
- Halim L, et al. 2022. Front Immunol. 13:836549. PubMed
- Zhou Y, et al. 2017. Front Cell Infect Microbiol. 7:457. PubMed
- Beatson RE, et al. 2021. Cell Rep Med. 2:100473. PubMed
- Kwon M, et al. 2020. Clin Cancer Res. 1644:26. PubMed
- Zhang D, et al. 2020. Oncoimmunology. 9:1744921. PubMed
- Lucas C, et al. 2021. Nature. Online ahead of print. PubMed
- Lam AJ, et al. 2021. Cell Reports. 36(5):109494. PubMed
- Li G, et al. 2021. Front Immunol. 12:800928. PubMed
- Zou F, et al. 2021. Mol Ther. 29:1794. PubMed
- Picard E, et al. 2019. Oncoimmunology. 8:e1527498. PubMed
- Zhang J, et al. 2022. Nature. 609:369. PubMed
- Alishah K, et al. 2021. J Transl Med. 19:482. PubMed
- Kotetsu Y, et al. 2021. Biomedicines. 9:. PubMed
- Li P, et al. 2022. Front Oncol. 12:917400. PubMed
- RY H, et al. 2016. Oncoimmunology. 6:e1249561. PubMed
- Li N, et al. 2020. Oncoimmunology. 9:1824643. PubMed
- Saraiva DP, et al. 2018. Front Immunol. 2.184027778. PubMed
- Wei J, et al. 2019. J Immunother Cancer. 7:209. PubMed
- Saygin C, et al. 2021. Leukemia. 35:3406. PubMed
- Stempin CC, et al. 2021. Cancers (Basel). 13:. PubMed
- McGowan J, et al. 2019. Front Immunol. 10:1553. PubMed
- RRID
- AB_2561717 (BioLegend Cat. No. 345011) AB_2561718 (BioLegend Cat. No. 345012)
- Structure
- Transmembrane protein containing immunoglobulin domain and mucin-like domain; can exist as a soluble form lacking mucin and transmembrane domains
- Distribution
-
Activated T cells, preferentially on Th1 cells, monocytes, dendritic cells
- Function
- Plays a role in regulating macrophage activation, T cell apoptosis and immune tolerance
- Ligand/Receptor
- Galectin-9
- Cell Type
- Dendritic cells, Monocytes, T cells, Th1, Tregs
- Biology Area
- Immunology, Inhibitory Molecules
- Molecular Family
- CD Molecules, Immune Checkpoint Receptors
- Antigen References
-
1. Hafler DA and Kuchroo V. 2008. J. Exp. Med. 205:2699.
2. Zhu C, et al. 2005. Nat. Immunol. 6:1245.
3. Wang F, et al. 2009. Immunobiology 214:342.
- Gene ID
- 84868 View all products for this Gene ID
- UniProt
- View information about CD366 on UniProt.org
